California Public Employees Retirement System’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,000
Closed -$971K 2758
2021
Q1
$971K Hold
25,000
﹤0.01% 2523
2020
Q4
$1.55M Sell
25,000
-500
-2% -$22.9K ﹤0.01% 2169
2020
Q3
$854K Buy
25,500
+800
+3% +$22.8K ﹤0.01% 2390
2020
Q2
$589K Buy
24,700
+10,230
+71% +$243K ﹤0.01% 2584
2020
Q1
$331K Hold
14,470
﹤0.01% 2608
2019
Q4
$410K Buy
+14,470
New +$364K ﹤0.01% 2820

Other funds holding STOK

California Public Employees Retirement System's STOK Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Stoke Therapeutics (STOK) in Q2 2021, closing a stake of 25,000 shares — an estimated $971K sold.

California Public Employees Retirement System first reported a position in STOK in Q4 2019 and held it in 6 quarters. The position peaked at $1.55M in Q4 2020. 97 funds tracked by Wall St. Rank hold STOK as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Stoke Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 25,000 Stoke Therapeutics shares in Q2 2021, an estimated $971K.
  • California Public Employees Retirement System first reported a position in Stoke Therapeutics in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Stoke Therapeutics position peaked at $1.55M in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.